Provided by Tiger Trade Technology Pte. Ltd.

ACADIA Pharmaceuticals

29.65
+0.15000.51%
Post-market: 29.650.00000.00%19:30 EDT
Volume:1.49M
Turnover:44.08M
Market Cap:5.11B
PE:13.50
High:29.78
Open:29.50
Low:29.15
Close:29.50
52wk High:30.96
52wk Low:19.69
Shares:172.31M
Float Shares:128.72M
Volume Ratio:0.95
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.20
EPS(LYR):2.30
ROE:35.74%
ROA:3.64%
PB:3.91
PE(LYR):12.89

Loading ...

Acadia Pharmaceuticals - European Commission Decision on Daybu Expected in Coming Months

THOMSON REUTERS
·
Jun 26

Acadia Pharmaceuticals - Daybu Marketing Authorization Would Cover EU, Iceland, Liechtenstein, Norway if Approved

THOMSON REUTERS
·
Jun 26

How Investors May Respond To ACADIA Pharmaceuticals (ACAD) ESOP-Linked Shelf Registration And Potential Dilution

Simply Wall St.
·
Jun 19

ACADIA Pharmaceuticals shareholders approved 5.21 million-share increase to 2024 equity plan

Reuters
·
May 30

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cardiff Oncology (CRDF), ACADIA Pharmaceuticals (ACAD) and Immunic (IMUX)

TIPRANKS
·
May 22

Assessing ACADIA Pharmaceuticals (ACAD) Valuation After Pipeline Progress And Product Rollouts

Simply Wall St.
·
May 21

A Look At ACADIA Pharmaceuticals (ACAD) Valuation After Mixed Q1 2026 Results And EU Trofinetide Setback

Simply Wall St.
·
May 11

ACADIA Pharmaceuticals Is Maintained at Buy by Citigroup

Dow Jones
·
May 09

ACADIA Pharmaceuticals Signals Confident Path After Q1 Call

TIPRANKS
·
May 08

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evotec AG (EVO), Vaxcyte (PCVX) and ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
May 08

RBC Capital Sticks to Their Buy Rating for ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
May 07

Analysts Offer Insights on Healthcare Companies: Kissei Pharmaceutical Co (OtherKSPHF), Recursion Pharmaceuticals (RXRX) and ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
May 07

Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (ACAD), Qiagen (QGEN) and Alcon (ALC)

TIPRANKS
·
May 07

Acadia Pharmaceuticals Q1 revenue rises on DAYBUE growth

Reuters
·
May 07

ACADIA Pharmaceuticals Q1 EPS $0.02 Misses $0.05 Estimate, Sales $268.062M Miss $280.710M Estimate

Benzinga Earnings
·
May 07

BRIEF-Acadia Pharmaceuticals Q1 EPS USD 0.02

Reuters
·
May 07

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 06

A Look At ACADIA Pharmaceuticals (ACAD) Valuation As Recent Returns Send Mixed Signals

Simply Wall St.
·
May 02

Acadia R&D chief Elizabeth Thompson to retire, company launches successor search

Reuters
·
May 01

ACADIA Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.z. Thompson, Ph.d., Head of Research and Development, Following a Distinguished Career

THOMSON REUTERS
·
May 01